Alterations in the hemostatic profiles of dogs with naturally occurring septic peritonitis

Journal of Veterinary Emergency and Critical Care

Volumn 23, Issue 1, 2013, Pages 14-22

  Bentley, Adrienne M ^b   Mayhew, Philipp D ^c   Culp, William T N ^c   Otto, Cynthia M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antithrombin; Protein C; Secondary peritonitis; Sepsis; Thromboelastography

Indexed keywords

NICKEL; TITANIUM; TITANIUM NICKELIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CELL COUNT; BLOOD CLOTTING; DOG; DOG DISEASE; FEMALE; HEMOSTASIS; MALE; PERITONITIS; PHYSIOLOGY; SEPSIS; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD CELL COUNT; BLOOD COAGULATION; DOG DISEASES; DOGS; FEMALE; HEMOSTASIS; MALE; NICKEL; PERITONITIS; SEPSIS; THROMBELASTOGRAPHY; TITANIUM;

ANIMALIA; CANIS FAMILIARIS;

EID: 84873168237     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/vec.12013     Document Type: Article

References (44)

1. Hardie EM, Rawlings CA, Calvert CA. Severe sepsis in selected small animal surgical patients. J Am Anim Hosp Assoc 1986; 22:33-41.
2. deLaforcade AM, Freeman LM, Shaw SP, et al. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003; 17:674-679.
3. deLaforcade AM, Rozanski EA, Freeman LM, et al. Serial evaluation of protein C and antithrombin in dogs with sepsis. J Vet Intern Med 2008; 22:26-30.
4. Ludwig LL, McLoughlin MA, Graves TK, et al. Surgical treatment of bile peritonitis in 24 dogs and 2 cats: a retrospective study (1987-1994). Vet Surg 1997; 26:90-98.
5. King LG. Postoperative complications and prognostic indicators in dogs and cats with septic peritonitis: 23 cases (1989-1992). J Am Vet Med Assoc 1994; 204:407-414.
6. Staatz AJ, Monnet E, Seim HB. Open peritoneal drainage versus primary closure for the treatment of septic peritonitis in dogs and cats: 42 cases (1993-1999). Vet Surg 2002; 31:174-180.
7. Mueller MG, Ludwig LL, Barton LJ. Use of closed-suction drains to treat generalized peritonitis in dogs and cats: 40 cases (1997-1999). J Am Vet Med Assoc 2001; 219:789-794.
8. Lanz OI, Ellison GW, Bellah JR, et al. Surgical treatment of septic peritonitis without abdominal drainage in 28 dogs. J Am Anim Hosp Assoc 2001; 37:87-92.
9. Greenfield CL, Walshaw R. Open peritoneal drainage for treatment of contaminated peritoneal cavity and septic peritonitis in dogs and cats: 24 cases (1980-1986). J Am Vet Med Assoc 1987; 191:100-105.
10. Woolfson JM, Dulisch ML. Open abdominal drainage in the treatment of generalized peritonitis in 25 dogs and cats. Vet Surg 1986; 15:27-32.
11. Bentley AM, Otto CM, Shofer FS. Comparison of dogs with septic peritonitis: 1988-1993 versus 1999-2003. J Vet Emerg Crit Care 2007; 17:391-398.
12. Lorente JA, Garcia-Frade LJ, Landin L, et al. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993; 103:1536-1542.
13. Karamarkovic A, Radenkovic D, Milic N, et al. Protein C as an early marker of severe septic complications in diffuse secondary peritonitis. World J Surg 2005; 29:759-765.
14. Fisher CJ, Yan SB. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 2000; 28:S49-S56.
15. Vangerow B, Shorr AF, Wyncoll D, et al. The protein C pathway: implications for the design of the RESPOND study. Crit Care 2007; 11(Suppl 5):S4.
16. Macias WL, Nelson DR. Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med 2004; 32:S223-S228.
17. Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005; 15:9-16.
18. Donahue SM, Brooks M, Otto CM. Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy. J Vet Emerg Crit Care 2011; 21:346-355.
19. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217:1500-1504.
20. Cohen E, Caprini J, Zuckerman L, et al. Evaluation of three methods used to identify accelerated coagulability. Thromb Res 1977; 10:577-604.
21. Caprini J, Zuckerman L, Cohen E, et al. The identification of accelerated coagulability. Thromb Res 1976; 9:167-180.
22. Hauptman JG, Walshaw R, Olivier NB. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg 1997; 26:393-397.
23. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1:43-46.
24. Streiner DL, Norman GR. Correction for multiple testing: is there a resolution? Chest 2011; 140:16-18.
25. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care 2009; 19:484-488.
26. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008; 22:357-365.
27. Goggs R, Wiinberg B, Kjelgaard-Hansen, et al. Serial assessment of the coagulation status of dogs with immune-mediated haemolytic anaemia using thromboelastography. Vet J 2012; 191(3):347-353.
28. Dhainaut JF, Shorr AF, Macias WL, et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005; 33:341-348.
29. Hopper K, Bateman S. An updated view of hemostasis: mechanisms of hemostatic dysfunction associated with sepsis. J Vet Emerg Crit Care 2005; 15:83-91.
30. Esmon CT. Inflammation and the activated PC anticoagulant pathway. Semin Thromb Hemost 2006; 32(Suppl 1):49-60.
31. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant-activated protein C. J Exp Med 2007; 204:2439-2448.
32. van Veen SQ, Levi M, van Vilet AK, et al. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis. Crit Care Med 2006; 34:2799-2805.
33. Schouten M, van't Veer C, Levi M, et al. Endogenous protein C inhibits activation of coagulation and transiently lowers bacterial outgrowth in murine Escherichia coli peritonitis. J Thromb Haemost 2011; 9:1072-1075.
34. Collins PW, Macchiavello LI, Lewis SJ, et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Brit J Haematol 2006; 135:220-227.
35. Yan SB, Helterbrand JD, Hartman DL, et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001; 120:915-922.
36. Gonano C, Sitzwohl C, Meitner E, et al. Four-day AT therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care 2006; 10:R160.
37. Kristensen AT, Wiinberg B, Jessen LR, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22:140-147.
38. Fenty RK, de Laforcade AM, Shaw SP, et al. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography. J Am Vet Med Assoc 2011; 238:463-467.
39. Goodwin LV, Goggs R, Chan DL, et al. Hypercoagulability in dogs with protein-losing enteropathy. J Vet Intern Med 2011; 25:273-277.
40. Smith AS, McMichael M, Galligan A, et al. Clot formation in canine whole blood as measured by rotational thromboelastometry is influenced by sample handling and coagulation activator. Blood Coagul Fibrinolysis 2010; 21:692-702.
41. Mineo HK, Garabed RB. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs. Am J Vet Res 2007; 68:1342-1347.
42. Levi M, van der Poll T. Recombinant human activated protein C: current insights into its mechanism of action. Crit Care 2007; 11(Suppl 5):S3.
43. Howell, MD, Talmor D, Schuetz P, et al. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care 2011; 39:322-327.
44. Shapiro NI, Trzeciak S, Hollander JE, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009; 37:96-104.